KR950031060A - 골다공증 치료용 약제학적 조성물 - Google Patents

골다공증 치료용 약제학적 조성물 Download PDF

Info

Publication number
KR950031060A
KR950031060A KR1019950009173A KR19950009173A KR950031060A KR 950031060 A KR950031060 A KR 950031060A KR 1019950009173 A KR1019950009173 A KR 1019950009173A KR 19950009173 A KR19950009173 A KR 19950009173A KR 950031060 A KR950031060 A KR 950031060A
Authority
KR
South Korea
Prior art keywords
osteoporosis
treatment
pharmaceutical composition
xanthohumol
active ingredient
Prior art date
Application number
KR1019950009173A
Other languages
English (en)
Other versions
KR100350564B1 (ko
Inventor
히로야스 도베
가즈유키 기타무라
오사무 고미야마
Original Assignee
사토 미쓰아키
훽스트 저팬 리미티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 사토 미쓰아키, 훽스트 저팬 리미티드 filed Critical 사토 미쓰아키
Publication of KR950031060A publication Critical patent/KR950031060A/ko
Application granted granted Critical
Publication of KR100350564B1 publication Critical patent/KR100350564B1/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/50—Methods involving additional extraction steps
    • A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/36—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction
    • B01D15/361—Ion-exchange
    • B01D15/363—Anion-exchange

Abstract

본 발명은, 활성성분으로서 크산토휴몰을 포함하는 골다공증 치료제에 관한 것이다. 호프 추출물로부터 수득된 크산토휴몰은 골 재흡수 억제 활성을 갖고 골다공증 치료제로서 유용하다.

Description

골다공증 치료용 약제학적 조성물
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (1)

1. 활성성분으로서 유효량의 하기 구조식(Ⅰ)의 크산토휴몰 및 약제학적으로 허용되는 담체를 포함하는, 골다공증 치료용 약제학적 조성물.
※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019950009173A 1994-04-21 1995-04-19 골다공증치료용약제학적조성물 KR100350564B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP94-082852 1994-04-21
JP6082852A JPH07285856A (ja) 1994-04-21 1994-04-21 骨粗鬆症治療剤

Publications (2)

Publication Number Publication Date
KR950031060A true KR950031060A (ko) 1995-12-18
KR100350564B1 KR100350564B1 (ko) 2002-12-16

Family

ID=13785904

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019950009173A KR100350564B1 (ko) 1994-04-21 1995-04-19 골다공증치료용약제학적조성물

Country Status (14)

Country Link
US (1) US5679716A (ko)
EP (1) EP0679393B1 (ko)
JP (1) JPH07285856A (ko)
KR (1) KR100350564B1 (ko)
AT (1) ATE162073T1 (ko)
AU (1) AU695696B2 (ko)
CA (1) CA2147419A1 (ko)
DE (1) DE69501419T2 (ko)
DK (1) DK0679393T3 (ko)
ES (1) ES2116642T3 (ko)
FI (1) FI951856A (ko)
HU (1) HUT71603A (ko)
NO (1) NO951498L (ko)
TW (1) TW284687B (ko)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6008208A (en) * 1995-10-23 1999-12-28 Osteoscreen, Inc. Compositions and methods for treating bone deficit conditions
US6241762B1 (en) 1998-03-30 2001-06-05 Conor Medsystems, Inc. Expandable medical device with ductile hinges
DE19939350B4 (de) * 1999-08-19 2005-04-07 Plantextrakt Gmbh & Co. Kg Hopfenextrakt und Verfahren zu dessen Herstellung
JP4249926B2 (ja) * 2000-01-27 2009-04-08 タカラバイオ株式会社 治療剤
WO2001076614A1 (fr) * 2000-04-10 2001-10-18 Takara Bio Inc. Remedes
US6352726B1 (en) * 2001-01-09 2002-03-05 S. S. Steiner, Inc. Method of killing protozoa
BR0208418A (pt) * 2001-04-05 2004-03-30 Unilever Nv Uso de isoxantohumol e/ou xantohumol, método para administrar isoxantohumol e/ou xantohumol a seres humanos em necessidade de receber um componente ani-inflamatório ou anti-envelhecimento, e, produto alimentìcio
FR2823672B1 (fr) * 2001-04-23 2004-03-12 Berkem Sa Extraits de houblon et leur utilisation dans la preparation d'un medicament ayant des proprietes oestrogenes
KR100993113B1 (ko) * 2002-02-14 2010-11-08 기린 홀딩스 가부시키가이샤 지질대사 개선용 조성물 및 식품
EP1503633A1 (en) * 2002-04-24 2005-02-09 Unilever N.V. Use of hop components in foods
DE10240065B4 (de) * 2002-08-30 2004-10-28 Hallertauer Hopfenveredlungsgesellschaft M.B.H. Verfahren zur Gewinnung von in Hopfen enthaltenem Xanthohumol und damit erhältlicher Xanthohumol-reicher Hopfenextrakt
DE50302729D1 (de) * 2002-12-18 2006-05-11 Doehler Gmbh Xanthohumol-haltiges Getränk
US20070059393A1 (en) * 2003-04-08 2007-03-15 Kirin Beer Kabushiki Kaisha Composition for inhibition or prevention of bone density
DE102004063125B4 (de) * 2004-12-22 2007-03-15 Ta-Xan-Ag Natürlicher Xanthohumol-haltiger Extrakt sowie das Verfahren zu dessen Herstellung und daraus hergestellte Getränke
WO2007016578A2 (en) * 2005-07-29 2007-02-08 Bioactives, Inc. Prenylflavonoid formulations
DE102006062264A1 (de) * 2006-12-22 2008-06-26 Joh. Barth & Sohn Gmbh & Co. Kg Verwendung von Xanthohumol zur Vorbeugung und/oder Bekämpfung von Lebererkrankungen
EP2392325A1 (en) 2010-06-04 2011-12-07 Universitätsklinikum Münster Compounds for the prevention and/or treatment of osteoarthrosis
KR101323150B1 (ko) * 2011-04-25 2013-10-30 충남대학교산학협력단 잔토휴몰을 함유하는 골다공증 예방 및 치료용 조성물
CN103371989A (zh) * 2012-04-24 2013-10-30 华东师范大学 黄腐酚在制备抑制破骨细胞分化和蚀骨功能的预防和/或治疗药物中的应用
US9782362B2 (en) 2012-07-26 2017-10-10 Ta-Xan Ag Uses of compositions containing a roasted extract and xanthohumol
JP6009498B2 (ja) * 2014-06-24 2016-10-19 国立大学法人京都大学 アルツハイマー病予防薬
US20180193287A1 (en) 2015-07-02 2018-07-12 John I. Haas, Inc. Hops-based substance and use of the substance
CN105477686B (zh) * 2015-11-30 2019-02-15 长春工业大学 一种包覆黄腐酚的纳米纤维膜

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3794744A (en) * 1972-05-10 1974-02-26 White Tomkins Ltd Purification of hop extracts
US4065574A (en) * 1975-08-29 1977-12-27 The Upjohn Company New method for controlling fungi using 4-chromone, 4-chromanone, 4-chromone oxime and 4-chromanone oxime compounds

Also Published As

Publication number Publication date
EP0679393A2 (en) 1995-11-02
ATE162073T1 (de) 1998-01-15
DE69501419T2 (de) 1998-06-25
CA2147419A1 (en) 1995-10-22
HUT71603A (en) 1996-01-29
NO951498L (no) 1995-10-23
AU1653595A (en) 1995-10-19
NO951498D0 (no) 1995-04-20
DE69501419D1 (de) 1998-02-19
EP0679393B1 (en) 1998-01-14
JPH07285856A (ja) 1995-10-31
EP0679393A3 (en) 1995-11-15
FI951856A0 (fi) 1995-04-19
ES2116642T3 (es) 1998-07-16
DK0679393T3 (da) 1998-09-14
US5679716A (en) 1997-10-21
HU9501121D0 (en) 1995-06-28
FI951856A (fi) 1995-10-22
KR100350564B1 (ko) 2002-12-16
AU695696B2 (en) 1998-08-20
TW284687B (ko) 1996-09-01

Similar Documents

Publication Publication Date Title
KR950031060A (ko) 골다공증 치료용 약제학적 조성물
KR950031059A (ko) 골다공증 치료용 약제학적 조성물
PT750618E (pt) Derivados de oxazolidinona e composicoes farmaceuticas que os contem
KR920019342A (ko) 골질환 치료제
KR960700742A (ko) 아토피성질환 치료약(atopic disease remedy)
ATE375341T1 (de) Thiadiazolylpiperazinderivate geeignet für die behandlung bzw. prävention von schmerzen
BR0116370A (pt) Composto, composição farmacêutica, uso de um composto, e, método de tratamento de uma doença ou condição mediada por hppar em um paciente.
BR0115109A (pt) Agentes terapêuticos e métodos de uso dos mesmos para a modulação da angiogênese
EP0882450A3 (en) Cholesterol-lowering composition comprising coenzyme Q
BR9509975A (pt) Formulação farmacêutica
KR950016760A (ko) 치질 치료제
MD1560F2 (en) Cyclic compounds, pharmaceutical compositions on base thereof and methods of treatment of infections or diseases provoked by retroviruses.
DE69333723D1 (de) Pharmazeutische zubereitung auf der basis von rhamnolipid gegen dermatologische erkrankungen
NO975726L (no) N-Hydroksyurea-derivater som anti-inflammatoriske midler
KR970061248A (ko) 알츠하이머병 치료용 1, 1, 2-트리페닐부트-1-엔 유도체
ATE40987T1 (de) Acetylenische phenoxypropanolderivate und pharmazeutische zusammensetzungen fuer die behandlung von bluthochdruck.
BR0015781A (pt) Composição farmacêutica para tratamento de doenças associadas à diminuição de massa óssea
DE69729201T2 (de) Sulfonfluoride zur behandlung von der alzheimerischen krankheit
KR970704442A (ko) 일시적인 병소 허혈에 의해 유발된 재관류 손상을 치료하기 위한 (S)-아데노실-L-메티오닌(SAMe) 및 그의 생리학상 적합한 염의 용도(Use of (S)-Adenosy-L-Methionine(SAMe) and lts Physiologically Compatible Salts for Treating Reperfusion Damage Triggered by Temporary Focal lschaemia)
DE69910787D1 (de) Neuartige, pharmazeutisch aktive verbindung
KR970706000A (ko) 자궁내막 유사분열의 저해 방법(methods of inihibiting endometrial mitoses)
KR970705387A (ko) 자궁내막암의 억제 방법(methods of inhibiting endometrial cancer)
KR880009644A (ko) 궤양성 대장질환 치료용 약한 조성물
BR0016646A (pt) Método para tratar um paciente que sofre de dor, e, composição farmacêutica
KR900017599A (ko) 종양 치료용 약학 조성물

Legal Events

Date Code Title Description
A201 Request for examination
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
LAPS Lapse due to unpaid annual fee